S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Krystal BiotechCellectisInhibrxAtara BiotherapeuticsAdverum Biotechnologies
SymbolNASDAQ:KRYSNASDAQ:CLLSNASDAQ:INBXNASDAQ:ATRANASDAQ:ADVM
Price Information
Current Price$71.65$19.31$26.56$15.89$10.96
52 Week RangeBuyHoldBuyBuyBuy
MarketRank™
Overall Score1.51.21.71.61.7
Analysis Score3.53.23.54.43.4
Community Score2.52.93.32.82.4
Dividend Score0.00.00.00.00.0
Ownership Score1.70.00.80.02.5
Earnings & Valuation Score0.00.00.60.60.0
Analyst Ratings
Consensus RecommendationBuyHoldBuyBuyBuy
Consensus Price Target$101.00$24.25$34.67$35.88$23.50
% Upside from Price Target40.96% upside25.58% upside30.52% upside125.77% upside114.42% upside
Trade Information
Market Cap$1.64 billion$855.67 million$1.10 billion$1.24 billion$1.10 billion
Beta1.22.59N/A2.651.72
Average Volume171,187447,061172,968876,792849,827
Sales & Book Value
Annual RevenueN/A$22.99 millionN/AN/A$250,000.00
Price / SalesN/A35.69N/AN/A4,287.38
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$11.72 per share$8.37 per shareN/A$5.37 per share$2.71 per share
Price / BookN/A2.31N/AN/A4.04
Profitability
Net Income$-19,090,000.00$-102,090,000.00N/A$-290,980,000.00$-64,490,000.00
EPS($1.20)($2.41)N/A($5.67)($1.01)
Trailing P/E RatioN/AN/A0.00N/AN/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/A-110.52%N/AN/AN/A
Return on Equity (ROE)-10.72%-23.56%N/A-94.86%-32.23%
Return on Assets (ROA)-10.40%-16.69%N/A-82.17%-28.02%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/A0.10%0.18%N/AN/A
Current Ratio39.96%6.11%3.80%9.41%28.53%
Quick Ratio39.96%6.00%3.80%9.41%28.53%
Ownership Information
Institutional Ownership Percentage73.05%33.30%36.63%N/A97.41%
Insider Ownership Percentage27.40%16.41%N/A4.30%12.40%
Miscellaneous
Employees5125375429114
Shares Outstanding22.20 million42.49 million37.71 million83.62 million97.80 million
Next Earnings Date5/3/2021 (Estimated)3/4/2021 (Confirmed)3/5/2021 (Estimated)5/5/2021 (Estimated)5/27/2021 (Estimated)
OptionableNot OptionableOptionableNot OptionableOptionableOptionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.